-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Wc77XN7a4b7DC9pjmtfPy6lJ38Rc4S9e2tbY+0QgQiytBLYeUZU12H4ve93GMf++ 7psNIqP7SCV81AlEJcuGaA== 0001354457-10-000082.txt : 20100405 0001354457-10-000082.hdr.sgml : 20100405 20100405100542 ACCESSION NUMBER: 0001354457-10-000082 CONFORMED SUBMISSION TYPE: 25-NSE CONFIRMING COPY: PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20100405 DATE AS OF CHANGE: 20100405 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ORE PHARMACEUTICAL HOLDINGS INC. CENTRAL INDEX KEY: 0001043914 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 061411336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25-NSE SEC ACT: 1934 Act SEC FILE NUMBER: 000-23317 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6176492001 MAIL ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ORE PHARMACEUTICALS INC. DATE OF NAME CHANGE: 20090720 FORMER COMPANY: FORMER CONFORMED NAME: GENE LOGIC INC DATE OF NAME CHANGE: 19970918 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NASDAQ Stock Market LLC CENTRAL INDEX KEY: 0001354457 IRS NUMBER: 521165937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25-NSE BUSINESS ADDRESS: STREET 1: 9600 BLACKWELL RD CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-978-4144 MAIL ADDRESS: STREET 1: 9600 BLACKWELL RD CITY: ROCKVILLE STATE: MD ZIP: 20850 25-NSE 1 primary_doc.xml X0203 0001354457 NASDAQ Stock Market LLC 0001043914 ORE PHARMACEUTICAL HOLDINGS INC. 000-23317
One Main Street, Suite 300 Cambridge MA MASSACHUSETTS 02142
617-649-2001 Common Stock 17 CFR 240.12d2-2(b) Amy Horton Associate General Counsel 2010-04-01 EX-99.25 2 orxedelistreason.txt Delisting Determination,The Nasdaq Stock Market, LLC, April 1, 2010, Ore Pharmaceutical Holdings Inc. The Nasdaq Stock Market, Inc. (the Exchange) has determined to remove from listing the common stock of Ore Pharmaceutical Holdings Inc. (the Company), effective at the opening of the trading session on April 12, 2010. Based on a review of the information provided by the Company, Nasdaq Staff determined that the Company no longer qualified for listing on the Exchange pursuant to Listing Rule 5550(a)(2). The Company was notified of the Staffs determination on March 16, 2010. The Company did not appeal the Staff determination to the Hearings Panel, and the Staff determination to delist the Company became final on March 25, 2010. -----END PRIVACY-ENHANCED MESSAGE-----